Stockreport

MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024

MaxCyte, Inc.  (MXCT) 
PDF ROCKVILLE, Md., Oct. 11, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform tec [Read more]